Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

News Conference News ESC 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

Caitlin E. Cox

September 05, 2025

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News EACTS 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Michael O'Riordan

October 07, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

Advertisement

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Will Semaglutide Change Cardiac Surgery? It Already Has

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

SCAAR Registry Delves Into Left Main Revascularization Outcomes

CV Care Around Noncardiac Surgery: New ESC Guidelines

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content